Professional Documents
Culture Documents
Membrane Filter Pore Size Tn6309en MK
Membrane Filter Pore Size Tn6309en MK
2
Table 2. Test Systems Colony Size Versus Pore Size
Temp. Time 0.2 µm 0.45 µm 0.7 µm 0.8 µm 1.2 µm Spread Plate
Microorganism Source Media (°C) (hours) 9
Colony Size:
Average Recovery
80
• Three test systems, B. diminuta, E. aerogenes, and
B. subtilis, showed differences in colony size with 60
pore size.
– Colonies grown on 1.2 and 0.8 µm filters were 40
3
• Although 0.22 µm filters retained the challenge, the Discussion
average recovery across all test systems was lower
than 0.45 µm filters. The above results were also confirmed over time
by various recovery studies6 with the standard
• Passage might be one reason why larger pore sizes microorganism B. diminuta and the standard 0.45 µm
(> 0.7 µm) showed lower recoveries than smaller mixed esters of cellulose membrane used in bacterial
pore sizes. retention validation tests.
Recovery of Challenge Versus Pore Size Furthermore, to avoid deriving conclusions valid only
120 for a specific filter material, both mixed esters of
Challenge
cellulose and hydrophilic polyvinylidene fluoride (PVDF)
100 filters with 0.22 µm and 0.45 µm pore sizes were
Challenge as well tested as described in Jeffrey Carter’s study,
Challenge
‘Evaluation of Recovery Filters for Use in Bacterial
Percent Recovery
80
Retention Testing of Sterilizing-Grade Filters’ 2. The
60
results showed that 0.22 µm filters despite their ability
Challenge
Challenge
to retain higher levels of bacteria, proved not to have
advantage over 0.45 µm filters in terms of bacterial
40
Filtrate recovery. The results showed equality of 0.22 µm and
Filtrate 0.45 µm filters when recovering non-stressed cells
20
and showed advantage of the 0.45 µm filters when
Filtrate recovering stressed cells.
0
0.2 µm 0.45 µm 0.7 µm 0.8 µm 1.2 µm
Pore Size Conclusion
Those studies confirmed that the standard 0.45 µm
Overall: pore size is the most appropriate for general
microbiological purposes. The 0.45 µm filters give
There was no universal pattern of results. Some the most consistent recoveries across a variety of test
microorganisms, such as Micrococcus luteus and systems and do not allow passage of the standard
Candida albicans showed no significant difference in 0.22 µm sterilizing filter challenge microorganism,
recovery or colony size with membrane pore size. Other B. diminuta, under typical filtration conditions.
organisms such as Pantoea agglomerans showed no
difference in colony size but had low recoveries on A membrane pore size larger than 0.45 µm can
1.2 and 0.22 µm membranes. increase flow rate, throughput, and, occasionally,
colony size (which makes the colonies easier to
The 0.45 µm membranes met this definition with all count). However, these larger pore sizes may not
test systems. Some test systems showed equivalent have sufficient retention and recovery for some
recoveries with other pore sizes but in no case were the microorganisms. Therefore, they are not well suited for
results significantly better. The lowest recoveries were total count applications.
seen with extremes of the pore size range (1.2 and
0.22 µm). Larger pore sizes can be used for enumerating specific
organisms, such as fecal coliforms or yeast. They
Recovery is much more complex than the retention of can also be used for difficult-to-filter samples where
microorganisms on the surface of a membrane filter improved throughput or larger sample volumes are
and the influence of pore size. It is a combination of needed. In both cases, the filter’s retention and
factors that may include: recovery performance should be documented for the
• The microorganism species and its condition—each target microorganism(s).
microorganism has the potential to react differently Pore sizes smaller than 0.45 µm have the disadvantage
• The sieving effects of the pore size as it relates to the of decreased flow rate, throughput, and, potentially,
retention of specific microorganisms recovery. Therefore, the greater retentive properties
of the 0.22 µm pore size have little benefit for the
• Type of medium and selectivity enumeration of bacteria, yeast, and molds in the
• Structure and chemistry of the membrane filter variety of liquids considered in this study.
• Environmental conditions (e.g., moisture, incubation, Last but not the least, for each bacterial retention
temperature) validation, our Validation Services laboratories
conduct a recovery study with 0.45 µm mixed esters
The effect of filter pore size on any specific of cellulose filters (or PVDF depending on the test
microorganism/medium combination is not always fluid) and customer drug product. The test results
predictable. If pore sizes other than those indicated by are documented in every bacterial retention validation
industry standards are used, they should be validated on protocol in order to provide documented evidence
relevant samples and media and compared to 0.45 µm. of the use of appropriate recovery filters. In case of
4
non-acceptable recovery, a flush might be necessary
for better recovery results. Should the recovery after
flushing still be non-acceptable, the tested fluid would
not be used as a challenge fluid due to the risk of false
negative results.
References
1. ASTM F838, Standard Test Method for Determining Bacterial
Retention of Membrane Filters Utilized for Liquid Filtration.
2. PDA Journal of Pharmaceutical Science & Technology. Evaluation of
Recovery Filters for Use in Bacterial Retention Testing of Sterilizing-
Grade Filters. Vol. 50, N° 3 - J. Carter.
3. Pharmacopoeia, USP <71>, EP 2.6.1, ChP 1101, JP 4.06 Sterility
Tests.
4. Pharmacopoeia, USP <61>, EP 2.6.12, ChP 1105, JP 4.05 Microbial
Examination of Nonsterile Products: Microbial Enumeration Tests.
5. PDA Journal of Pharmaceutical Science and Technology: Technical
Report No. 26, Sterilizing Filtration of Liquids.
6. Merck study report number 00016731-PQPSR1.
Merck KGaA
Frankfurter Strasse 250
64293 Darmstadt, Germany
MerckMillipore.com
© 2020 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved. Merck, the vibrant M and BioReliance are MK_TN6309EN Ver. 1.0
trademarks of Merck KGaA, Darmstadt, Germany or its affiliates. All other trademarks are the property of their respective owners. 31510
Detailed information on trademarks is available via publicly accessible resources. 04/2020